ArticleTrends in pharmacological sciences2024

Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis.

Niki F Brisnovali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.